Prevacid, Nexium DTC Ads Target Former Vioxx Patients
Executive Summary
Proton pump inhibitor marketers are using direct-to-consumer print ads to target patients coming off Merck's COX-2 inhibitor Vioxx by highlighting PPIs' efficacy in reducing NSAID-related ulcers